About Accelrys

Accelrys develops and commercializes scientific business intelligence software for the integration, mining, analysis, modeling and simulation, management and interactive reporting of scientific data. We are a NASDAQ-listed public company (ACCL) that combines financial stability and a strong market position.

Innovation

Our 450 employees offer a unique blend of industry knowledge and expertise in science, software development, and systems implementation. We offer high-quality service around the globe. Over 150 PhD scientists maintain our products and innovate to extend and apply them. New science emerges via our product development, post-doctoral, sabbatical, and consortium programs.
Learn more about innovation at Accelrys »

Partners

To ensure 'best-of-breed' science and information technology, we also collaborate with leading academic and industrial scientists, and partner with other technology vendors.
Learn more about our partnerships »

Customers

Our customers are the world's leading pharmaceutical, chemical, biotechnology, nanotechnology, academic, and government research organizations.
See a list of select Accelrys customers »

Accelrys History

Accelrys combines experience and intellectual property developed during twenty-five years of serving research organizations with modeling and simulation, bioinformatics, cheminformatics, and middleware technology.

Accelrys was founded in 2001, bringing together five specialist companies— Molecular Simulations Inc. (MSI), Synopsys Scientific Systems, Oxford Molecular, the Genetics Computer Group (GCG®), and Synomics Ltd. In 2004, Accelrys acquired SciTegic Inc. These companies, in turn, had combined a total of seventeen software companies over the previous decade— many of them startups from leading academic institutes. Accelrys thus encompasses a rich pedigree of scientific achievement.